Klinikum Esslingen GmbH — Clinical Trial Site

88 Registered trials

43 Currently recruiting

Organisation

Klinikum Esslingen GmbH

Location

Esslingen Am Neckar, Germany

Identifier

ORG-100043190

Address

Hirschlandstraße 97, Oberesslingen, 73730, Germany

Departments

-
049021: Frauenheilkunde und Geburtshilfe
Allg. Innere Med., Onkologie, Hämatologie, Gastroenterologie und Infektiologie
Allgemein- und Viszeralchirurgie
Allgemeine Innere Medizin, Onkologie / Haematologie, Gastroenterologie und Infektiologie
Angiologie und Pneumologie
Cancer Center Esslingen
Cardiology, Angiology, Pneumology
Clinic for Cardiology, Angiology and Pneumology
Department for Gynecology and Obstetrics
Department of Cardiology, Angiology and Pulmonology
Department Oncology/Hematology, Gastroenterology and Infectious Diseases
Frauenklinik
Gynäkologisches Krebszentrum
Gynecology
Gynecology and Obstetrics
Hematology
Innere Medizin
Innere Medizin, Pneumologie
Innere Medizin/Hämatologie/Onkologie
Kardiologie, Angiologie und Pneumologie
Klinik fuer Frauenheilkunde und Geburtshilfe
Klinik fuer Kardiologie Angiologie und Pneumologie
Klinik fuer Kardiologie und Pneumologie
Klinik fuer Kardiologie, Angiologie Und Pneumologie
Klinik für Allgemeine Innere Medizin, Onkologie/Hämatologie,
Klinik für Allgemeine Innere Medizin, Onkologie/Hämatologie, Gastroenterologie und Infektiologie
Klinik für Allgemeine, Innere Medizin, Onkologie/Hämatologie, Gastroenterologie und Infektiologie
Klinik für Frauenheilkunde und Geburtshilfe
Klinik für Frauenheilkunde, Brustzentrum
Klinik für Kardiologie, Angiologie und Pneumologie
Klinik für Kardiologie, Angiologie und Pneumologie Studienbüro Haus 7
Klinik für Onkologie, Gastroenterologie und Allgemeine Innere Medizin
Klinik für Onkologie/Hämatologie
Klinikum Esslingen
n.a
n/a
Oncology
Onkologie & Hämatologie
Onkologie/ Hämatologie, Gastroenterologie und Infektiologie
Pneumologie
Pneumologie im Thoraxzentrum Südwest
Pneumologische Onkologie, Klinik für Kardiologie, Angiologie und Pneumologie
Pneumology
Thoraxzentrum Esslingen Stuttgart (TESS)
Thoraxzentrum Südwest

Clinical trials at this site (88)

Search interface

HOVON 156 AML: Treatment for acute myeloid leukemia (AML) or myelodysplastic syndrome with a FLT3 mutation with gilteritinib or midostaurin … Ended

2022-502478-18-00 Acute Myeloid Leukemia (AML) 4 2019-12-20
Randomized Phase III Study of Standard Intensive Chemotherapy versus Intensive Chemotherapy with CPX-351 in Adult Patients with Newly Diagno… Ended

2023-503670-21-00 Patients with newly diagnosed AML and intermediate- or 5 2019-08-28
Treatment for previously untreated patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) with an IDH1 or IDH2 mutatio… Ended

2022-502832-37-00 Acute myeloid leukemia 5 2019-03-01
DANTE / FLOT8 A randomized, open-label Phase II/III efficacy and safety study of atezolizumab in combination with FLOT versus FLOT alone in … Ended

2024-514945-12-00 locally advanced resectable adenocarcinoma of the oesop 10 2018-09-03
Chemo +/- Pembrolizumab (MK-3475) as Perioperative Therapy for Stage II, IIIA-Resectable IIIB (N2) NSCLC Ended

2023-504820-24-00 Neoadjuvant/Adjuvant treatment for participants with Re 5 2018-03-21
A Study Evaluating the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Patients with Advanced or Metastatic Non-Small C… Ended

2023-507500-31-00 Advanced or metastatic Non-small cell lung cancer (NSCL 10 2017-08-22
Adjuvant chemotherapy with gemcitabine and cisplatin compared to standard of care after curative intent resection of cholangiocarcinoma and … Ended

2024-517340-61-00 Patients after curative intent resection of cholangioca 5 2024-11-19
PEARLDIFER - A Phase II study of pemigatinib after curative local therapy in locally advanced intrahepatic cholangiocarcinoma (iCCA) harbori… Ended

2024-512018-16-00 locally advanced intrahepatic cholangiocarcinoma (iCCA) 4 2022-11-11
Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed S… Ended

2024-513559-34-00 Small Cell Lung Cancer (SCLC) 5 2022-07-19
Phase 3 study of SBRT ± pembrolizumab for participants with unresectable Stage I or II NSCLC Ended

2022-500413-11-00 Unresected Stage I or II Non-Small Cell Lung Cancer (NS 5 2019-06-17
This is a phase III randomised, double-blind, placebo-controlled, multicentre, global study to assess the effectiveness and safety of standa… Ended

2022-502747-35-00 Newly diagnosed advanced (FIGO stage III-IV) high grade 5 2019-02-18
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negati… Ended

2023-508472-11-00 Patients with early breast cancer 5 2018-06-13
Perioperative treatment of locally advanced resectable gastric or GEJ adenocarcinoma Ended

2023-509595-42-00 Gastric and gastroesophageal junction (GEJ) adenocarcin 5 2017-10-31
HD21 Ended

2024-518022-33-00 Advanced Stage of Hodgkin Lymphoma 5 2016-07-15
A randomized, phase 3 trial with anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) versus placebo for patients with early stage NSCLC af… Ended

2023-509137-39-00 Stage IB (T ≥ 4 cm), II and IIIA NSCLC 5 2015-11-06
A Study to Compare the Efficacy and Safety of a Combined Regimen of Obinutuzumab and Venetoclax (GDC-0199/ABT-199) Versus Obinutuzumab and … Ended

2023-504034-22-00 Chronic Lymphocytic Leukemia (CLL) 5 2014-12-18